AIM ImmunoTech
30 hedge funds and large institutions have $2.43M invested in AIM ImmunoTech in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 7 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
9% less funds holding
Funds holding: 33 → 30 (-3)
23% less capital invested
Capital invested by funds: $3.15M → $2.43M (-$714K)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$120K |
| 2 |
AC
Armistice Capital
New York
|
+$84.1K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$21K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$17.2K |
| 5 |
VF
Virtu Financial
New York
|
+$15.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$46.6K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$26K |
| 3 |
FWM
ForthRight Wealth Management
Alpharetta,
Georgia
|
-$7.45K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$7.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.83K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| $108 | -$233 | -7 | -64% |
|
|
TWC
27
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $43 | – | – | – |
|
|
FFA
28
Farther Finance Advisors
San Francisco,
California
| $41 | +$67 | +2 | New |
|
29
JP Morgan Chase
New York
| $37 | – | – | – |
|
|
HNB
30
Huntington National Bank
Columbus,
Ohio
| $15 | – | – | – |
|
|
31
UBS Group
Zurich,
Switzerland
| $6 | -$7.1K | -213 | Closed |
|
|
TSS
32
Two Sigma Securities
New York
| – | -$46.6K | -1,251 | Closed |
|
|
FWM
33
ForthRight Wealth Management
Alpharetta,
Georgia
| – | -$7.45K | -200 | Closed |
|
34
CIBC Private Wealth Group
Atlanta,
Georgia
| – | -$1.84K | -50 | Closed |
|
|
AF
35
Advisornet Financial
Minnetonka,
Minnesota
| – | -$186 | -5 | Closed |
|
|
CC
36
Cypress Capital
Franklin,
Tennessee
| – | -$75 | -2 | Closed |
|
AIM Hedge Fund Activity: Q3 2024 in Review
30 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q3 2024, worth a combined $2.43M — down 23% from $3.15M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of AIM and 4 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 6 added.
The largest buyer was Citadel Advisors, adding an estimated $120K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $46.6K sold.
- 30 institutional investors held AIM ImmunoTech (AIM) as of Q3 2024, down from 33 in Q2 2024.
- Funds reported $2.43M of AIM ImmunoTech stock for Q3 2024, down 23% quarter-over-quarter.
- 4 funds opened new AIM ImmunoTech positions in Q3 2024 and 7 closed out, a net change of -3 holders.
- The largest AIM ImmunoTech buyer in Q3 2024 was Citadel Advisors, an estimated $120K added.
- The largest AIM ImmunoTech seller in Q3 2024 was Two Sigma Securities, an estimated $46.6K sold.
Based on aggregated 13F filings for Q3 2024.